Evidence map›Paper›PMID 30147887›Full record

ArticleClinical case reports2018

Gynecomastia after euthyroidism restoration in a patient with type 1 diabetes and Graves' disease.

Valeria Calcaterra, Edoardo Clerici, Valeria Ceolin, Corrado Regalbuto, Daniela Larizza

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease.Endocrinology, diabetes & metabolism case reports · 2021
    Article
  2. Article
  3. GYNAECOMASTIA APPEARED THREE DAYS AFTER STARTING METHIMAZOLE.Acta endocrinologica (Bucharest, Romania : 2005)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Valeria CalcaterraPediatric Endocrinology Unit Department of Maternal and Children's Health Fondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy.ORCID 0000-0002-2137-5974
Edoardo ClericiPediatric Endocrinology Unit Department of Maternal and Children's Health Fondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy.
Valeria CeolinPediatric Endocrinology Unit Department of Maternal and Children's Health Fondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy.
Corrado RegalbutoPediatric Endocrinology Unit Department of Maternal and Children's Health Fondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy.
Daniela LarizzaPediatric Endocrinology Unit Department of Maternal and Children's Health Fondazione IRCCS Policlinico S. Matteo and University of Pavia Pavia Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In patients with autoimmune disease, gynecomastia should not be considered as 1 of the first signs of hyperthyroidism, rather it is a breast pathology that can be present even when euthyroidism restoration is achieved. It is unknown whether the autoimmune nature of thyroid disorders or simply the hyperthyroidism effects breast changes.

Indexed as

euthyroidismGraves’ diseasegynecomastiatype 1 diabetes

Identifiers

PMID30147887
PMCPMC6099052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.